Lovethatch的个人主页 - 老虎社区

Lovethatch

Lovethatch

暂无个人介绍

IP属地：未知

40关注

1粉丝

0主题

0勋章

2021-07-05

$Scienjoy Holding Corp.(SJ)$那麼多好消息可是一直跌📉？

2021-06-29

I see

Why Tesla Stock Jumped on Monday

2021-06-25

👍🏻

GH Research PLC Announces Pricing of Initial Public Offering

2021-04-27

要退了？

@乖乖董:$Tonix Pharmaceuticals Holding Co(TNXP)$为啥机构持股没了，机构全出了？

2021-04-12

$Coinbase Global, Inc.(COIN)$幾點會開跑？

2021-04-07

$Color Star Technology Co. Ltd(CSCW)$幾時會上～

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3576922039448359","uuid":"3576922039448359","gmtCreate":1613828015488,"gmtModify":1617707285293,"name":"Lovethatch","pinyin":"lovethatch","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":40,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":155461353,"gmtCreate":1625449342572,"gmtModify":1631889256214,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576922039448359","authorIdStr":"3576922039448359"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SJ\">$Scienjoy Holding Corp.(SJ)$</a>那麼多好消息可是一直跌📉？","listText":"<a href=\"https://laohu8.com/S/SJ\">$Scienjoy Holding Corp.(SJ)$</a>那麼多好消息可是一直跌📉？","text":"$Scienjoy Holding Corp.(SJ)$那麼多好消息可是一直跌📉？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/155461353","isVote":1,"tweetType":1,"viewCount":963,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":159887359,"gmtCreate":1624955991471,"gmtModify":1633946549481,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576922039448359","authorIdStr":"3576922039448359"},"themes":[],"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/159887359","repostId":"1122223844","repostType":4,"repost":{"id":"1122223844","kind":"news","pubTimestamp":1624955173,"share":"https://ttm.financial/m/news/1122223844?lang=&edition=full","pubTime":"2021-06-29 16:26","market":"us","language":"en","title":"Why Tesla Stock Jumped on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1122223844","media":"Motley Fool","summary":"Could the electric car maker's recall in China actually be a good thing?","content":"<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Tesla</b>(NASDAQ:TSLA)&nbsp;jumped on Monday. The electric car maker's shares rose as much as 2.5%. </p>\n<p>The&nbsp;growth stock's gain oddly follows an announcement of a voluntary recall of nearly 300,000 vehicles in China. Interestingly, a close look at the recall shows a reason why investors may be cheering the move.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6453a3bfcd6cd1f24760fb76ce55e549\" tg-width=\"700\" tg-height=\"466\"><span>IMAGE SOURCE: TESLA.</span></p>\n<p><b>So what</b></p>\n<p>China's vehicle safety organization, State Administration for Market Regulation (SAMR), announced over the weekend that Tesla was voluntarily recalling over 285,000 vehicles in the country. An issue with Tesla's driver-assist system in its Model 3 and Y vehicles in the market reportedly meant that the technology could be accidentally turned on or off under particular circumstances.</p>\n<p>Though it's considered a recall, drivers won't need to take their cars to a service station. The fix has been deployed as a remote software update. It could be argued that the rapid fix via a software update puts the spotlight on the company's software prowess. This could impress not only investors, but also Chinese consumers.</p>\n<p><b>Now what</b></p>\n<p>The stock's sharp gain on Monday adds to its recent momentum. Shares are up more than 20% since June 3. However, the stock is still down substantially from an all-time high of just over $900.</p>\n<p>Investors will get insight into Tesla's recent performance when the company reports second-quarter results next month. The report is usually released at some point in the second half of July.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Tesla Stock Jumped on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Tesla Stock Jumped on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/28/why-tesla-stock-jumped-on-monday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Tesla(NASDAQ:TSLA) jumped on Monday. The electric car maker's shares rose as much as 2.5%. \nThe growth stock's gain oddly follows an announcement of a voluntary recall of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/why-tesla-stock-jumped-on-monday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/06/28/why-tesla-stock-jumped-on-monday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122223844","content_text":"What happened\nShares of Tesla(NASDAQ:TSLA) jumped on Monday. The electric car maker's shares rose as much as 2.5%. \nThe growth stock's gain oddly follows an announcement of a voluntary recall of nearly 300,000 vehicles in China. Interestingly, a close look at the recall shows a reason why investors may be cheering the move.\nIMAGE SOURCE: TESLA.\nSo what\nChina's vehicle safety organization, State Administration for Market Regulation (SAMR), announced over the weekend that Tesla was voluntarily recalling over 285,000 vehicles in the country. An issue with Tesla's driver-assist system in its Model 3 and Y vehicles in the market reportedly meant that the technology could be accidentally turned on or off under particular circumstances.\nThough it's considered a recall, drivers won't need to take their cars to a service station. The fix has been deployed as a remote software update. It could be argued that the rapid fix via a software update puts the spotlight on the company's software prowess. This could impress not only investors, but also Chinese consumers.\nNow what\nThe stock's sharp gain on Monday adds to its recent momentum. Shares are up more than 20% since June 3. However, the stock is still down substantially from an all-time high of just over $900.\nInvestors will get insight into Tesla's recent performance when the company reports second-quarter results next month. The report is usually released at some point in the second half of July.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":122015653,"gmtCreate":1624587893472,"gmtModify":1633950858131,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576922039448359","authorIdStr":"3576922039448359"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122015653","repostId":"2146293990","repostType":4,"repost":{"id":"2146293990","kind":"news","pubTimestamp":1624583160,"share":"https://ttm.financial/m/news/2146293990?lang=&edition=full","pubTime":"2021-06-25 09:06","market":"us","language":"en","title":"GH Research PLC Announces Pricing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2146293990","media":"StreetInsider","summary":"DUBLIN, June 24, 2021 /PRNewswire/ -- GH Research PLC, a clinical-stage biopharmaceutical company de","content":"<p>DUBLIN, June 24, 2021 /PRNewswire/ -- <a href=\"https://laohu8.com/S/GHRS\">GH Research PLC</a>, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced the pricing of its initial public offering in the United States of 10,000,000 ordinary shares at an initial public offering price of $16 per share for total gross proceeds of approximately $160 million. All of the ordinary shares are being offered by GH Research <a href=\"https://laohu8.com/S/PLC\">PLC</a>. The ordinary shares are expected to begin trading on the Nasdaq Global Market on June 25, 2021 under the ticker symbol \"GHRS.\" The offering is expected to close on June 29, 2021, subject to customary closing conditions. In addition, GH Research PLC has granted the underwriters a 30-day option to purchase up to an additional 1,499,999 ordinary shares at the initial public offering price, less underwriting discounts and commissions.</p>\n<p><img src=\"https://static.tigerbbs.com/a94eadf8f71ac3070a72d96fa1977551\" tg-width=\"400\" tg-height=\"69\" referrerpolicy=\"no-referrer\"></p>\n<p>Cowen and Stifel are acting as joint book-running managers for the offering. Canaccord Genuity and JMP Securities are acting as lead managers for the offering.</p>\n<p>A registration statement relating to these securities became effective on June 24, 2021. The offering will be made only by means of a prospectus. When available, copies of the final prospectus related to the offering can be obtained from any of the joint book-running managers for the offering: Cowen and Company, LLC, c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (833) 297-2926 or by email at PostSaleManualRequests@broadridge.com; or Stifel, Nicolaus &amp; Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720 or by email at syndprospectus@stifel.com. For the avoidance of doubt, such prospectus will not constitute a \"prospectus\" for the purposes of Regulation (EU) 2017/1129 (the \"Prospectus Regulation\") and will not have been reviewed by any competent authority in any European Union member state or the United Kingdom.</p>\n<p>A registration statement relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (the \"SEC\"). Copies of the registration statement can be accessed through the SEC's website at www.sec.gov. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.</p>\n<p>In any member state of the European Economic Area (the \"EEA\") this announcement and any offering are only addressed to and directed at persons who are \"qualified investors\" (\"Qualified Investors\") within the meaning of the Prospectus Regulation. In the United Kingdom, this announcement and any offering are only addressed to and directed at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the \"Order\"), or (ii) who fall within Article 49(2)(a) to (d) of the Order, and (iii) to whom it may otherwise lawfully be communicated (all such persons being referred to as \"Relevant Persons\").</p>\n<p>This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to and will only be engaged with (i) in the United Kingdom, Relevant Persons, and (ii) in any member state of the EEA, Qualified Investors.</p>\n<p>Contact:investors@ghres.com</p>\n<p><b>About GH Research PLC </b></p>\n<p>GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GH Research PLC Announces Pricing of Initial Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGH Research PLC Announces Pricing of Initial Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 09:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603637><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DUBLIN, June 24, 2021 /PRNewswire/ -- GH Research PLC, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced the...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603637\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GHRS":"GH Research PLC"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603637","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146293990","content_text":"DUBLIN, June 24, 2021 /PRNewswire/ -- GH Research PLC, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced the pricing of its initial public offering in the United States of 10,000,000 ordinary shares at an initial public offering price of $16 per share for total gross proceeds of approximately $160 million. All of the ordinary shares are being offered by GH Research PLC. The ordinary shares are expected to begin trading on the Nasdaq Global Market on June 25, 2021 under the ticker symbol \"GHRS.\" The offering is expected to close on June 29, 2021, subject to customary closing conditions. In addition, GH Research PLC has granted the underwriters a 30-day option to purchase up to an additional 1,499,999 ordinary shares at the initial public offering price, less underwriting discounts and commissions.\n\nCowen and Stifel are acting as joint book-running managers for the offering. Canaccord Genuity and JMP Securities are acting as lead managers for the offering.\nA registration statement relating to these securities became effective on June 24, 2021. The offering will be made only by means of a prospectus. When available, copies of the final prospectus related to the offering can be obtained from any of the joint book-running managers for the offering: Cowen and Company, LLC, c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (833) 297-2926 or by email at PostSaleManualRequests@broadridge.com; or Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720 or by email at syndprospectus@stifel.com. For the avoidance of doubt, such prospectus will not constitute a \"prospectus\" for the purposes of Regulation (EU) 2017/1129 (the \"Prospectus Regulation\") and will not have been reviewed by any competent authority in any European Union member state or the United Kingdom.\nA registration statement relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (the \"SEC\"). Copies of the registration statement can be accessed through the SEC's website at www.sec.gov. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.\nIn any member state of the European Economic Area (the \"EEA\") this announcement and any offering are only addressed to and directed at persons who are \"qualified investors\" (\"Qualified Investors\") within the meaning of the Prospectus Regulation. In the United Kingdom, this announcement and any offering are only addressed to and directed at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the \"Order\"), or (ii) who fall within Article 49(2)(a) to (d) of the Order, and (iii) to whom it may otherwise lawfully be communicated (all such persons being referred to as \"Relevant Persons\").\nThis announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to and will only be engaged with (i) in the United Kingdom, Relevant Persons, and (ii) in any member state of the EEA, Qualified Investors.\nContact:investors@ghres.com\nAbout GH Research PLC \nGH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.","news_type":1,"symbols_score_info":{"GHRS":0.9}},"isVote":1,"tweetType":1,"viewCount":1542,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374717062,"gmtCreate":1619481097556,"gmtModify":1634273145477,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576922039448359","authorIdStr":"3576922039448359"},"themes":[],"htmlText":"要退了？","listText":"要退了？","text":"要退了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/374717062","repostId":"374806027","repostType":1,"repost":{"id":374806027,"gmtCreate":1619434748269,"gmtModify":1619434748269,"author":{"id":"3521458621054210","authorId":"3521458621054210","name":"乖乖董","avatar":"https://static.tigerbbs.com/0e96142689e22ca484aaa6e16cae9e01","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521458621054210","authorIdStr":"3521458621054210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TNXP\">$Tonix Pharmaceuticals Holding Co(TNXP)$</a>为啥机构持股没了，机构全出了？","listText":"<a href=\"https://laohu8.com/S/TNXP\">$Tonix Pharmaceuticals Holding Co(TNXP)$</a>为啥机构持股没了，机构全出了？","text":"$Tonix Pharmaceuticals Holding Co(TNXP)$为啥机构持股没了，机构全出了？","images":[{"img":"https://static.tigerbbs.com/5872d07d542c07dab7a564820f0ce048","width":"1080","height":"2340"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/374806027","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":342467433,"gmtCreate":1618237750622,"gmtModify":1634294234336,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576922039448359","authorIdStr":"3576922039448359"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/COIN\">$Coinbase Global, Inc.(COIN)$</a>幾點會開跑？","listText":"<a href=\"https://laohu8.com/S/COIN\">$Coinbase Global, Inc.(COIN)$</a>幾點會開跑？","text":"$Coinbase Global, Inc.(COIN)$幾點會開跑？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/342467433","isVote":1,"tweetType":1,"viewCount":2029,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":341364594,"gmtCreate":1617784491818,"gmtModify":1631886368829,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576922039448359","authorIdStr":"3576922039448359"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CSCW\">$Color Star Technology Co. Ltd(CSCW)$</a>幾時會上～","listText":"<a href=\"https://laohu8.com/S/CSCW\">$Color Star Technology Co. Ltd(CSCW)$</a>幾時會上～","text":"$Color Star Technology Co. Ltd(CSCW)$幾時會上～","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/341364594","isVote":1,"tweetType":1,"viewCount":1918,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":342467433,"gmtCreate":1618237750622,"gmtModify":1634294234336,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576922039448359","idStr":"3576922039448359"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/COIN\">$Coinbase Global, Inc.(COIN)$</a>幾點會開跑？","listText":"<a href=\"https://laohu8.com/S/COIN\">$Coinbase Global, Inc.(COIN)$</a>幾點會開跑？","text":"$Coinbase Global, Inc.(COIN)$幾點會開跑？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/342467433","isVote":1,"tweetType":1,"viewCount":2029,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":155461353,"gmtCreate":1625449342572,"gmtModify":1631889256214,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576922039448359","idStr":"3576922039448359"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SJ\">$Scienjoy Holding Corp.(SJ)$</a>那麼多好消息可是一直跌📉？","listText":"<a href=\"https://laohu8.com/S/SJ\">$Scienjoy Holding Corp.(SJ)$</a>那麼多好消息可是一直跌📉？","text":"$Scienjoy Holding Corp.(SJ)$那麼多好消息可是一直跌📉？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/155461353","isVote":1,"tweetType":1,"viewCount":963,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":159887359,"gmtCreate":1624955991471,"gmtModify":1633946549481,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576922039448359","idStr":"3576922039448359"},"themes":[],"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/159887359","repostId":"1122223844","repostType":4,"repost":{"id":"1122223844","kind":"news","pubTimestamp":1624955173,"share":"https://ttm.financial/m/news/1122223844?lang=&edition=full","pubTime":"2021-06-29 16:26","market":"us","language":"en","title":"Why Tesla Stock Jumped on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1122223844","media":"Motley Fool","summary":"Could the electric car maker's recall in China actually be a good thing?","content":"<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Tesla</b>(NASDAQ:TSLA)&nbsp;jumped on Monday. The electric car maker's shares rose as much as 2.5%. </p>\n<p>The&nbsp;growth stock's gain oddly follows an announcement of a voluntary recall of nearly 300,000 vehicles in China. Interestingly, a close look at the recall shows a reason why investors may be cheering the move.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6453a3bfcd6cd1f24760fb76ce55e549\" tg-width=\"700\" tg-height=\"466\"><span>IMAGE SOURCE: TESLA.</span></p>\n<p><b>So what</b></p>\n<p>China's vehicle safety organization, State Administration for Market Regulation (SAMR), announced over the weekend that Tesla was voluntarily recalling over 285,000 vehicles in the country. An issue with Tesla's driver-assist system in its Model 3 and Y vehicles in the market reportedly meant that the technology could be accidentally turned on or off under particular circumstances.</p>\n<p>Though it's considered a recall, drivers won't need to take their cars to a service station. The fix has been deployed as a remote software update. It could be argued that the rapid fix via a software update puts the spotlight on the company's software prowess. This could impress not only investors, but also Chinese consumers.</p>\n<p><b>Now what</b></p>\n<p>The stock's sharp gain on Monday adds to its recent momentum. Shares are up more than 20% since June 3. However, the stock is still down substantially from an all-time high of just over $900.</p>\n<p>Investors will get insight into Tesla's recent performance when the company reports second-quarter results next month. The report is usually released at some point in the second half of July.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Tesla Stock Jumped on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Tesla Stock Jumped on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/28/why-tesla-stock-jumped-on-monday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Tesla(NASDAQ:TSLA) jumped on Monday. The electric car maker's shares rose as much as 2.5%. \nThe growth stock's gain oddly follows an announcement of a voluntary recall of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/why-tesla-stock-jumped-on-monday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/06/28/why-tesla-stock-jumped-on-monday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122223844","content_text":"What happened\nShares of Tesla(NASDAQ:TSLA) jumped on Monday. The electric car maker's shares rose as much as 2.5%. \nThe growth stock's gain oddly follows an announcement of a voluntary recall of nearly 300,000 vehicles in China. Interestingly, a close look at the recall shows a reason why investors may be cheering the move.\nIMAGE SOURCE: TESLA.\nSo what\nChina's vehicle safety organization, State Administration for Market Regulation (SAMR), announced over the weekend that Tesla was voluntarily recalling over 285,000 vehicles in the country. An issue with Tesla's driver-assist system in its Model 3 and Y vehicles in the market reportedly meant that the technology could be accidentally turned on or off under particular circumstances.\nThough it's considered a recall, drivers won't need to take their cars to a service station. The fix has been deployed as a remote software update. It could be argued that the rapid fix via a software update puts the spotlight on the company's software prowess. This could impress not only investors, but also Chinese consumers.\nNow what\nThe stock's sharp gain on Monday adds to its recent momentum. Shares are up more than 20% since June 3. However, the stock is still down substantially from an all-time high of just over $900.\nInvestors will get insight into Tesla's recent performance when the company reports second-quarter results next month. The report is usually released at some point in the second half of July.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":341364594,"gmtCreate":1617784491818,"gmtModify":1631886368829,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576922039448359","idStr":"3576922039448359"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CSCW\">$Color Star Technology Co. Ltd(CSCW)$</a>幾時會上～","listText":"<a href=\"https://laohu8.com/S/CSCW\">$Color Star Technology Co. Ltd(CSCW)$</a>幾時會上～","text":"$Color Star Technology Co. Ltd(CSCW)$幾時會上～","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/341364594","isVote":1,"tweetType":1,"viewCount":1918,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":122015653,"gmtCreate":1624587893472,"gmtModify":1633950858131,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576922039448359","idStr":"3576922039448359"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122015653","repostId":"2146293990","repostType":4,"repost":{"id":"2146293990","kind":"news","pubTimestamp":1624583160,"share":"https://ttm.financial/m/news/2146293990?lang=&edition=full","pubTime":"2021-06-25 09:06","market":"us","language":"en","title":"GH Research PLC Announces Pricing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2146293990","media":"StreetInsider","summary":"DUBLIN, June 24, 2021 /PRNewswire/ -- GH Research PLC, a clinical-stage biopharmaceutical company de","content":"<p>DUBLIN, June 24, 2021 /PRNewswire/ -- <a href=\"https://laohu8.com/S/GHRS\">GH Research PLC</a>, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced the pricing of its initial public offering in the United States of 10,000,000 ordinary shares at an initial public offering price of $16 per share for total gross proceeds of approximately $160 million. All of the ordinary shares are being offered by GH Research <a href=\"https://laohu8.com/S/PLC\">PLC</a>. The ordinary shares are expected to begin trading on the Nasdaq Global Market on June 25, 2021 under the ticker symbol \"GHRS.\" The offering is expected to close on June 29, 2021, subject to customary closing conditions. In addition, GH Research PLC has granted the underwriters a 30-day option to purchase up to an additional 1,499,999 ordinary shares at the initial public offering price, less underwriting discounts and commissions.</p>\n<p><img src=\"https://static.tigerbbs.com/a94eadf8f71ac3070a72d96fa1977551\" tg-width=\"400\" tg-height=\"69\" referrerpolicy=\"no-referrer\"></p>\n<p>Cowen and Stifel are acting as joint book-running managers for the offering. Canaccord Genuity and JMP Securities are acting as lead managers for the offering.</p>\n<p>A registration statement relating to these securities became effective on June 24, 2021. The offering will be made only by means of a prospectus. When available, copies of the final prospectus related to the offering can be obtained from any of the joint book-running managers for the offering: Cowen and Company, LLC, c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (833) 297-2926 or by email at PostSaleManualRequests@broadridge.com; or Stifel, Nicolaus &amp; Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720 or by email at syndprospectus@stifel.com. For the avoidance of doubt, such prospectus will not constitute a \"prospectus\" for the purposes of Regulation (EU) 2017/1129 (the \"Prospectus Regulation\") and will not have been reviewed by any competent authority in any European Union member state or the United Kingdom.</p>\n<p>A registration statement relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (the \"SEC\"). Copies of the registration statement can be accessed through the SEC's website at www.sec.gov. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.</p>\n<p>In any member state of the European Economic Area (the \"EEA\") this announcement and any offering are only addressed to and directed at persons who are \"qualified investors\" (\"Qualified Investors\") within the meaning of the Prospectus Regulation. In the United Kingdom, this announcement and any offering are only addressed to and directed at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the \"Order\"), or (ii) who fall within Article 49(2)(a) to (d) of the Order, and (iii) to whom it may otherwise lawfully be communicated (all such persons being referred to as \"Relevant Persons\").</p>\n<p>This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to and will only be engaged with (i) in the United Kingdom, Relevant Persons, and (ii) in any member state of the EEA, Qualified Investors.</p>\n<p>Contact:investors@ghres.com</p>\n<p><b>About GH Research PLC </b></p>\n<p>GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GH Research PLC Announces Pricing of Initial Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGH Research PLC Announces Pricing of Initial Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 09:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18603637><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DUBLIN, June 24, 2021 /PRNewswire/ -- GH Research PLC, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced the...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18603637\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GHRS":"GH Research PLC"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18603637","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146293990","content_text":"DUBLIN, June 24, 2021 /PRNewswire/ -- GH Research PLC, a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced the pricing of its initial public offering in the United States of 10,000,000 ordinary shares at an initial public offering price of $16 per share for total gross proceeds of approximately $160 million. All of the ordinary shares are being offered by GH Research PLC. The ordinary shares are expected to begin trading on the Nasdaq Global Market on June 25, 2021 under the ticker symbol \"GHRS.\" The offering is expected to close on June 29, 2021, subject to customary closing conditions. In addition, GH Research PLC has granted the underwriters a 30-day option to purchase up to an additional 1,499,999 ordinary shares at the initial public offering price, less underwriting discounts and commissions.\n\nCowen and Stifel are acting as joint book-running managers for the offering. Canaccord Genuity and JMP Securities are acting as lead managers for the offering.\nA registration statement relating to these securities became effective on June 24, 2021. The offering will be made only by means of a prospectus. When available, copies of the final prospectus related to the offering can be obtained from any of the joint book-running managers for the offering: Cowen and Company, LLC, c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (833) 297-2926 or by email at PostSaleManualRequests@broadridge.com; or Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720 or by email at syndprospectus@stifel.com. For the avoidance of doubt, such prospectus will not constitute a \"prospectus\" for the purposes of Regulation (EU) 2017/1129 (the \"Prospectus Regulation\") and will not have been reviewed by any competent authority in any European Union member state or the United Kingdom.\nA registration statement relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (the \"SEC\"). Copies of the registration statement can be accessed through the SEC's website at www.sec.gov. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.\nIn any member state of the European Economic Area (the \"EEA\") this announcement and any offering are only addressed to and directed at persons who are \"qualified investors\" (\"Qualified Investors\") within the meaning of the Prospectus Regulation. In the United Kingdom, this announcement and any offering are only addressed to and directed at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the \"Order\"), or (ii) who fall within Article 49(2)(a) to (d) of the Order, and (iii) to whom it may otherwise lawfully be communicated (all such persons being referred to as \"Relevant Persons\").\nThis announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to and will only be engaged with (i) in the United Kingdom, Relevant Persons, and (ii) in any member state of the EEA, Qualified Investors.\nContact:investors@ghres.com\nAbout GH Research PLC \nGH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.","news_type":1,"symbols_score_info":{"GHRS":0.9}},"isVote":1,"tweetType":1,"viewCount":1542,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":374717062,"gmtCreate":1619481097556,"gmtModify":1634273145477,"author":{"id":"3576922039448359","authorId":"3576922039448359","name":"Lovethatch","avatar":"https://static.tigerbbs.com/a0fb3d1e880db90e142ed924bea5128b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3576922039448359","idStr":"3576922039448359"},"themes":[],"htmlText":"要退了？","listText":"要退了？","text":"要退了？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/374717062","repostId":"374806027","repostType":1,"repost":{"id":374806027,"gmtCreate":1619434748269,"gmtModify":1619434748269,"author":{"id":"3521458621054210","authorId":"3521458621054210","name":"乖乖董","avatar":"https://static.tigerbbs.com/0e96142689e22ca484aaa6e16cae9e01","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3521458621054210","idStr":"3521458621054210"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TNXP\">$Tonix Pharmaceuticals Holding Co(TNXP)$</a>为啥机构持股没了，机构全出了？","listText":"<a href=\"https://laohu8.com/S/TNXP\">$Tonix Pharmaceuticals Holding Co(TNXP)$</a>为啥机构持股没了，机构全出了？","text":"$Tonix Pharmaceuticals Holding Co(TNXP)$为啥机构持股没了，机构全出了？","images":[{"img":"https://static.tigerbbs.com/5872d07d542c07dab7a564820f0ce048","width":"1080","height":"2340"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/374806027","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}